Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.
Batchu
S N
SN
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Lee
S B
SB
Qadhi
R S
RS
Chaudhary
K R
KR
El-Sikhry
H
H
Kodela
R
R
Falck
J R
JR
Seubert
J M
JM
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D000081:Acetamides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002316:Cardiotonic Agents / Q000494:pharmacology*; D015687:Cell Hypoxia / Q000187:drug effects; D002460:Cell Line; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D066298:In Vitro Techniques; D008297:Male; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D009203:Myocardial Infarction / Q000517:prevention & control; D017202:Myocardial Ischemia / Q000188:drug therapy*; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology / Q000517:prevention & control*; D032383:Myocytes, Cardiac / Q000187:drug effects; D009829:Oleic Acids / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051381:Rats; D018055:Receptors, Eicosanoid / Q000037:antagonists & inhibitors
C558112:(13-(2-(butylamino)-2-oxoacetamido)tridec-8(Z)-enoic acid); C558111:(13-(3-propylureido)tridec-8-enoic acid); C494022:14,15-eicosa-5-enoic acid; D000081:Acetamides; D002316:Cardiotonic Agents; D004791:Enzyme Inhibitors; D009829:Oleic Acids; D000081082:Phosphoinositide-3 Kinase Inhibitors; D018055:Receptors, Eicosanoid; D015126:8,11,14-Eicosatrienoic Acid